Close

Analyst Ratings for Atara Biotherapeutics (ATRA) [Neutrals]

All Latest Ratings for ATRA

ATRA Rating Summary

ATRA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ATRA
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $4.20 (+491.5%) * Over Last 12-Mos
Rating Score: 3.3 / 10   Percentile Rank: 30%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/9/2023 Evercore ISI Johnathan Miller Downgrade In Line
(Outperform)		 N/A
(N/A)		 1.21
(0.71)		 -41.32% Details
11/9/2023 H.C. Wainwright Robert Burns Downgrade Neutral
(Buy)		 N/A
(N/A)		 1.21
(0.71)		 -41.32% Details